<DOC>
	<DOCNO>NCT01848873</DOCNO>
	<brief_summary>To evaluate efficacy Amlodipine-folic Acid Tablets reduction blood pressure plasma homocystein .</brief_summary>
	<brief_title>Efficacy Amlodipine-folic Acid Tablets Reduction Blood Pressure Plasma Homocysteine</brief_title>
	<detailed_description>Traditional risk factor estimate account part cardiovascular disease ( CVD ) risk . Non-traditional risk factor increase homocysteine concentration believe causally related CVD . The interactive effect hypertension hyperhomocysteinemia risk CVD receive great attention . Methylenetetrahydrofolate reductase ( MTHFR ) main regulatory enzyme homocysteine metabolism . MTHFR convert 5 , 10-methylene-THF 5-methyl-THF . Polymorphism MTHFR C677T lead reduction enzyme activity , may lead increased concentration plasma homocysteine low level serum folate , particularly low folate intake . In present study , seek ass : ( 1 ) efficacy safety Amlodipine-folic Acid Tablets lower blood pressure homocystein patient mild moderate hypertension hyperhomocysteinemia ( hcy≥10μmol/L ) ; ( 2 ) blood pressure homocysteine-lowering efficacy Amlodipine-folic Acid Tablets modify individual methylenetetrahydrofolate reductase ( MTHFR ) C677T polymorphism . In , 756 patient mild moderate hypertension hyperhomocysteinemia recruit 18 hospital different Chinese region . All hospital certify clinical pharmacology center State Food Drug Administration ( SFDA ) China . Eligible subject randomly double-blindly assigned one three treatment group : 1 ) amlodipine tablet ( 5 mg , control group ) ; 2 ) amlodipine-folic acid tablet ( 5mg amlodipine combine 0.4 mg folic acid , low FA group ) ; 3 ) amlodipine-folic acid tablet ( 5 mg amlodipine combine 0.8 mg folic acid , high FA group ) , daily 8 week . The allocation participant program independent statistical coordinating center , encrypt , send study center . Tablet container label name trial allocate concealment number . The participant , care partner , staff directly involve trial blind intervention period trial . Demographic clinical information obtain baseline . Blood pressure examine baseline every two week total period 8 week . Blood homocysteine folate concentration examine baseline 4 8 week trial . MTHFR C677T genotype determine study subject . All analysis perform accord principle intention treat .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperhomocysteinemia</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Aged 1875 year ; 2 . Seated systolic blood pressure ( SBP ) 140 mmHg 180 mmHg and/or seat diastolic blood pressure 90 mmHg 110 mmHg ; 3 . Plasma homocysteine ≥10umol/L； 4 . Signed write informed consent . 1 . Pregnant woman woman within lactation period ; 2 . Hypersensitive calcium channel blocker ( CCB ) folic acid ; 3 . Easily hypersensitiveness 4 . Diagnosed secondum hypertension skeptical secondum hypertension ; 5 . Severe hypertension ( sedentary systolic blood pressure≥180mmHg and/or sedentary diastolic blood pressure≥110mmHg ) 6 . Severe disease : 1 . Cardiovascular system : 2 . Diagnosed cardia insufficiency ( NYHAⅢ level high ) ; Hypertrophic obstructive cardiomyopathy ( HOCM ) ; Clinical significantly valvular disease heart ( VDH ) ; Acute coronary syndrome coronary artery interventional therapy coronary artery bypass graft within three month ; Severe arrhythmia atrial flutter , atrial fibrillation , atrioventricular block Ⅱ level , et al ; 3 . Alimentary system : 4 . Active virus hepatitis ; Any alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , galactosylhydroxylysyl glucosyltransferase ( GGT ) , alkaline phosphatase ( ALP ) , total bilirubin ( TBIL ) , direct bilirubin ( DB ) 2 time 's normal value upper limit , albumin ( ALB ) ≤30g/L ; Stomach bulk resect gastrojejunostomy , stomach intestine malabsorption ; 5 . Urinary system : 6 . Serum creatinine≥200μmol/L ; Diagnosed stenosis renal artery , solitary kidney , renal transplantation ; 7 . Endocrine system : 8 . Type 1 diabetes mellitus uncontrolled type 2 diabetes mellitus ( fast glucose≥11.1mmol/L ) ; Diagnosed uncontrolled hyperthyrosis ; 9 . Respiratory system : 10 . Pulmonary heart disease , chronic obstructive lung disease ; 11 . Nervous psyche system : 12 . Transient ischemia attach ( TIA ) stoke within 3 month ; Severe peripheral nerve vegetative nerve functional disturbance ; Psyche nervous system dysfunction ; Drugs alcohol dependence . 13 . Others : 14 . Malignant tumor , malnutrition , haematogenesis dysfunction , et al ; 7 . Obvious sign abnormal laboratory examination ; 8 . Taking antihypertensive drug unwilling stop ; 9 . Taking folic acid Vitamin B group unwilling stop .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hyperhomocysteinemia</keyword>
	<keyword>Amlodipine-folic acid tablet</keyword>
	<keyword>Hypertension</keyword>
	<keyword>MTHFR C677T</keyword>
</DOC>